title: Proceedings of the 2013 Viral Clearance Symposium (Princeton, NJ).
authors.affiliation: Senior Principal Scientist Merck, Sharp and Dohme Biologics Process Development Kenilworth, NJ.
authors.forename: David
authors.initials: D
authors.lastname: Roush
authors.affiliation: Research Biologist Division of Monoclonal Antibodies Center for Drug Evaluation and Research U.S. Food and Drug Administration Silver Spring, MD.
authors.forename: Kurt
authors.initials: K
authors.lastname: Brorson
authors.affiliation: Senior Vice President, Scientific and Regulatory Affairs Parental Drug Association Bethesda, MD.
authors.forename: Rich
authors.initials: R
authors.lastname: Levy
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D003226:Congresses as Topic / Q000639:trends*; D006801:Humans; D009515:New Jersey; D019562:Viral Load / Q000187:drug effects* / Q000502:physiology; D014764:Viral Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism*
chemical_list: D000998:Antiviral Agents; D014764:Viral Proteins